{
  "name" : "dacemirror.sci-hub.se_journal-article_698d3ab9ed7a81aab253245ede503dd4_yuan2019.pdf",
  "metadata" : {
    "source" : "META",
    "title" : "ZIF nano-dagger coated gauze for antibiotic-free wound dressing",
    "authors" : [ "Yuan Yuan", "Hong Wu", "Hongfang Lu", "Yiran Zheng", "Jackie Y. Ying" ],
    "emails" : [ ],
    "sections" : [ {
      "heading" : null,
      "text" : "This journal is©The Royal Society of Chemistry 2019 Chem. Commun., 2019, 55, 699--702 | 699\nCite this:Chem. Commun., 2019, 55, 699\nZIF nano-dagger coated gauze for antibiotic-free wound dressing†\nYuan Yuan,‡a Hong Wu,‡b Hongfang Lu,b Yiran Zheng,a Jackie Y. Ying*b and Yugen Zhang *a\nNano-dagger coated gauze was bactericidal against both Gram-\npositive and Gram-negative bacteria, with log reduction 47 for\nEscherichia coli (E. coli) and Staphylococcus aureus (S. aureus).\nCompared with the commercially available Ag gauze, the ZIF-L\nnano-dagger coated gauze was more biocompatible with a lower\nhaemolytic activity, less cytotoxicity and improved wound healing\nperformance. Animal studies showed that the ZIF-L coated gauze\ncan effectively kill bacteria in a S. aureus wound infection model in\nmice. This novel nano-dagger coated gauze offers an effective and\nsafe alternative for patients to protect against wound infections.\nThis study demonstrates the first application of a MOF coating as an\nantibiotic-free wound dressing with potent antimicrobial activity\nand improved biocompatibility.\nInfection in both acute and chronic wounds may lead to considerable morbidity, mortality, and increased costs.1 A tissue bacterial bioburden of greater than 1 105 (or at least 1 106 bacteria per gram of tissue) can be present without clinical signs of infection, and can deleteriously affect wound healing.2–4 Attempts at controlling the tissue bacterial bioburden have faced difficulties. Systemically administered antibiotics usually do not effectively decrease the level of bacteria in local and chronic wound infections. Drugs may not penetrate well into the wounds due to poor blood flow and the presence of dead tissue, especially for patients with physiological or metabolic problems such as diabetes. Moreover, inappropriate use of systemic antibiotics, such as the topical use of antibiotics that are applied for purposes other than wound infections, may lead to allergy, toxicity and development of resistance.\nThe most common strategy to protect wounds from bacterial colonization is to use (i) a topical bacterial barrier dressing, which can be a physical barrier, such as films that are gaspermeable but are able to block liquids, or (ii) an antimicrobial dressing that releases microbicidal molecules, such as silver, iodine, chlorhexidine and polycationic compounds, into the wound bed to block bacterial transmission by killing the bacteria.5 For burns and other wounds where there is a high risk of infection, an antimicrobial dressing is often selected as it can prevent bacterial colonization and subsequent biofilm formation, or treat established infections.\nAmong the diversified antimicrobial wound dressing products, silver products are extensively marketed.6 However, the use of silver dressings in wound care has recently faced considerable challenges.7 Silver products can be cytotoxic to healthy cells in the wound area, such as keratinocytes and fibroblasts, delay re-epithelialization and potentially cause drug-resistance development.8–13 Hence, there is a need for antibacterial dressings that are effective, non-toxic and low cost, and do not induce resistance.\nIn recent years, the biomedical applications of metal–organic frameworks (MOFs) have attracted increasing attention. Colbalt,14,15 silver,16,17 copper,18–20 and zinc21 based MOF materials are reported to have certain antimicrobial effect. They act as a reservoir of metal components, providing a gradual release of metal ions and resulting in a metal ion based antibacterial action.22 We have developed a general and simple method to grow zinc-based zeolitic imidazolate framework (ZIF) nano-dagger arrays (ZIF-L) on a wide range of surfaces.23 The nano-dagger arrays possess excellent microbicidal activity. Unlike the MOFs that kill bacteria by releasing metal components, the ZIF-L nano-dagger arrays prevent bacterial growth by rupturing the adhered microbial cells using the sharp tips of the nano-arrays; this represents a physical killing mechanism without the involvement of chemicals or antibiotics. In this study, the nanodagger arrays have been successfully coated onto cotton gauze. The antimicrobial activity of the coated gauze was tested against E. coli and S. aureus. The ZIF-L coated gauze was evaluated for the treatment of S. aureus infected wounds in mice, and compared to the commercially available silver dressing.§ a Institute of Bioengineering and Nanotechnology, 31 Biopolis Way, The Nanos #04-01, Singapore 138669, Singapore. E-mail: ygzhang@ibn.a-star.edu.sg b NanoBio Lab, 31 Biopolis Way, The Nanos, Singapore 138669, Singapore. E-mail: jyying@ibn.a-star.edu.sg † Electronic supplementary information (ESI) available: Experimental section, supporting figures, supporting tables and computational details. See DOI: 10.1039/c8cc08568d ‡ These two authors contributed equally to this work.\nReceived 26th October 2018, Accepted 10th December 2018\nDOI: 10.1039/c8cc08568d\nrsc.li/chemcomm\nChemComm\nCOMMUNICATION\nPu bl\nis he\nd on\n1 1\nD ec\nem be\nr 20\n18 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf N\new E\nng la\nnd o\nn 1/\n21 /2\n01 9\n2: 30\n:1 4\nA M\n.\nView Article Online View Journal | View Issue\n700 | Chem. Commun., 2019, 55, 699--702 This journal is©The Royal Society of Chemistry 2019\nResults and discussion: ZIF-L coating on cotton gauze: The ZIF-L coating was formed through in situ heterogeneous nucleation of ZIF-L crystals on the substrate. The cotton gauze was vertically immersed in the precursor solution, 2-methylimidazole (2-MeIm) solution. When Zn(NO3)2 was added, nucleation and crystal growth occurred simultaneously on the cotton gauze. SEM showed that the uncoated gauze has a smooth surface, while the coated gauze was covered by a thick layer of ZIF-L nanodagger arrays (Fig. 1). Each nano-dagger looked like half of a leaf with a sharp tip extending vertically from the cotton gauze. They were tightly patterned on the gauze surface, and the distance between the nano-daggers was less than 500 nm. The thickness of the ZIF-L coating was B2 mm, similar to that of the ZIF-L coating on other substrates.23\nIn vitro antimicrobial activity of the ZIF-L coated gauze: The antimicrobial activity of the ZIF-L coated gauze was evaluated against two common wound pathogens, Gram-negative E. coli and Gram-positive S. aureus using the JIS method.24 Fig. 2 shows that the ZIF-L coated cotton gauze exhibited an extraordinary bactericidal activity against E. coli and S. aureus. In each test of 24 h incubation, no bacterial colony was observed on the ZIF-L coated gauze while the number of bacteria on the uncoated gauze reached 1010 1011 CFU per sample. These remarkable antimicrobial results indicated that the ZIF-L nano-dagger coated gauze could efficiently kill both Gram-positive and Gramnegative bacterial strains.\nTo gain insights into the antimicrobial mechanism, the morphological differences between S. aureus in contact with\nthe ZIF-L coated gauze and those in contact with the uncoated gauze were examined via FESEM (Fig. 3). S. aureus incubated with the uncoated gauze for 3 h exhibited a round and smooth morphology with intact cell walls. In contrast, significant deformation was observed for S. aureus incubated with the ZIF-L coated gauze. Nano-daggers penetrating the cell membrane were seen in Fig. 3b. In fact, nano-structured bactericidal surfaces have attracted considerable research interest recently.25,26 The well-accepted mechanism of this is that the cell death is primarily caused by the microbial membrane rupture via cellular adhesion.27,28 The ZIF-L coating is a new design of a nanostructured surface that involves imposing positive charges on the surface to enhance the electrostatic interaction between bacterial cells and surface nano-arrays, thereby improving the killing efficacy.23\nIn vitro biocompatibility: A hemolysis test is the most common method to determine the hemo-compatibility of biomaterials. Interaction of red blood cells (RBCs) with biomaterials or their extracts in solution can cause the release of intracellular hemoglobin. The hemolytic activity can be determined as a function of hemoglobin release by measuring the absorbance of the supernatant at 576 nm using a microplate reader. In our study, hemolysis caused by ZIF-L dagger particles and the ZIF-L coated gauze was measured using mouse RBCs. Negligible hemolysis was observed for ZIF-L particles at all the concentrations tested after 1 h of incubation at 37 1C (Fig. 4a). Similarly, the hemolytic activity of the ZIF-L coated gauze was analyzed and compared with the Ag coated gauze. No detectable hemolysis (o1%) was observed for the ZIF-L coated gauze during the first 3 h, while the Ag gauze caused 9.5% and 14.0% hemolysis after 1 h and 3 h, respectively (Fig. 4b). After 24 h of incubation, the ZIF-L\nFig. 1 Structure of the nano-dagger ZIF-L coating on cotton gauze. FESEM images of (a and b) the as-received cotton gauze and (c and d) the ZIF-L coated gauze."
    }, {
      "heading" : "Communication ChemComm",
      "text" : "Pu bl\nis he\nd on\n1 1\nD ec\nem be\nr 20\n18 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf N\new E\nng la\nnd o\nn 1/\n21 /2\n01 9\n2: 30\n:1 4\nA M\n.\nView Article Online\nThis journal is©The Royal Society of Chemistry 2019 Chem. Commun., 2019, 55, 699--702 | 701\ncoated gauze induced 8.7% hemolysis, while the Ag gauze led to 59.9% hemolysis. These results demonstrated that the ZIF-L coated gauze has much higher in vitro blood compatibility than the Ag gauze.\nThe cytotoxicity of the ZIF-L coated gauze was evaluated using human primary dermal fibroblasts. Optical micrographs (Fig. 5a–d) show fibroblast cells attached on the ZIF-L coated and non-coated gauze after 24 h of incubation. No significant morphological difference was observed between cells attached on the ZIF-L coated gauze and those on the uncoated gauze. The viabilities of human dermal fibroblasts on the uncoated gauze (control) and the ZIF-L coated gauze were B93% and 74%, respectively after 1 h of incubation (Fig. 5e). The mild cytotoxicity of the ZIF-L coated gauze might be due to its sharp and stiff surface. The Ag gauze was severely cytotoxic to fibroblasts, reducing the cell viability to 0.85% after 1 h of incubation.\nThe cytotoxicity of the ZIF-L nano-dagger particles was also evaluated. Over 90% of the human dermal fibroblasts were viable when the concentration of ZIF-L particles was not higher than 250 mg ml 1 (Fig. 5f). Cell viability decreased when the ZIF-L particle concentration was increased further. Cell viability was 64% at a particle concentration of 2000 mg ml 1, indicating a fairly low cytotoxicity even at high ZIF-L concentration.\nTreatment of S. aureus infected wounds: The in vivo application of the ZIF-L coated gauze to treat bacterial infection was tested on mice using the S. aureus infected wound model.29 Two symmetrical full-thickness skin defects were created on the back of each mouse, and inoculated with S. aureus (see Fig. 6). The ZIF-L coated gauze, the uncoated gauze, or the UrgoTuls Silver gauze was then placed to cover the wounds. All of the mice survived during the study. They showed signs of bacterial infection, such as weight loss and becoming dull. After 4 days,\nmice with the ZIF-L coated gauze or the Ag-coated gauze started to recover and became active again, while mice with the uncoated gauze were still weak and less active for up to 1 week after surgery.\nThe infected wounds 7 days and 11 days after the treatment are shown in Fig. 7a. A purulent discharge around ulcers and increased wound areas were observed in the group of mice with uncoated gauzes over the first week, suggesting active wound infection. The untreated wounds were significantly different from the wounds treated with the ZIF-L coated gauze or the Ag-coated gauze. The wounds covered by uncoated gauzes were much larger than those treated with ZIF-L coated gauzes or Ag-coated gauzes on day 7 (Fig. 7a). The former were still open with purulent discharge on day 11, while the latter were closed and epithelialized. These results illustrated that the wound closure was accelerated after treatment with the ZIF-L coated gauze and the Ag-coated gauze.\nThe antimicrobial efficacy of each gauze sample was evaluated based on the number of viable S. aureus recovered from the wounds after 11 days (Fig. 7b). The numbers of S. aureus recovered from the wounds treated with the ZIF-L coated gauze and the Ag-coated gauze were 98.7% and 91.4% lower than those with the uncoated gauze. The viable bacteria in wounds\nFig. 5 ZIF-L coated gauze exhibits good biocompatibility. Light micrographs of (a and b) the uncoated cotton gauze and (c and d) the ZIF-L coated gauze (a and c) before and (b and d) after 24 h of incubation with human primary dermal fibroblasts. Scale bar = 50 mm. Cell viability of human primary dermal fibroblasts after 1 h of incubation (e) with the uncoated cotton gauze, the ZIF-L coated gauze and the UrgoTuls Silver gauze (the Ag gauze), and (f) with ZIF-L nano-dagger particles at different concentrations.\nFig. 6 Photographs of mice with S. aureus infected full-thickness excision for the antimicrobial activity test of the ZIF-L coated gauze. (a) Both the epidermis and the dermis were surgically removed using a 6 mm biopsy punch to create two full-thickness wounds on the dorsally shaved mouse. Next, 20 ml of S. aureus solution was inoculated on each wound. (b) After 5 min, the ZIF-L coated cotton gauze was applied on the wound. For comparison, mice were applied with uncoated cotton gauze (as negative control) and the Ag-coated wound dressing (as positive control). (c) The wounds were covered with Tegaderm (3M, Singapore). (d) Each mouse was then wrapped with a bandage to protect the wounds."
    }, {
      "heading" : "ChemComm Communication",
      "text" : "Pu bl\nis he\nd on\n1 1\nD ec\nem be\nr 20\n18 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf N\new E\nng la\nnd o\nn 1/\n21 /2\n01 9\n2: 30\n:1 4\nA M\n. View Article Online\n702 | Chem. Commun., 2019, 55, 699--702 This journal is©The Royal Society of Chemistry 2019\ntreated with the ZIF-L coated gauze were less than those in wounds treated with the Ag-coated gauze, although the difference was not statistically significant ( p = 0.16).\nImages of hematoxylin and eosin (H&E) stained wounds after 11 days of treatment are shown in Fig. 8. For the wounds with the uncoated gauze, re-epithelialization was initiated, but most of the wound was still exposed (Fig. 8a–d). Wounds treated with the ZIF-L coated gauze or the Ag-coated gauze have completed the re-epithelialization process, and the epidermal layer was well structured (Fig. 8e–j). These histological results were consistent with the wound appearances shown in Fig. 7a. The in vivo studies indicated that accelerated bacteria clearance and wound healing were achieved by the topical application of the ZIF-L coated gauze.\nIn summary, ZIF nano-dagger coated cotton gauze has been examined as an antibiotic-free antimicrobial wound dressing for the first time. The ZIF-L coated gauze demonstrated bactericidal activity against E. coli and S. aureus. Hemolysis and cytotoxicity tests showed that the ZIF-L coated gauze was more biocompatible than the commercially available Ag-coated gauze. A study using the fullthickness S. aureus infected mouse model showed that the ZIF-L coated gauze not only killed bacteria, but also accelerated the healing of bacteria-infected wounds. Hence, the ZIF-L coated gauze has potential as a topical antimicrobial dressing. It provides a promising protocol for antimicrobial wound dressing that is green and safe.\nThis work was supported by the Institute of Bioengineering and Nanotechnology and the NanoBio Lab (Biomedical Research Council, Agency for Science, Technology and Research, Singapore), and the National Research Foundation (Prime Minister’s Office, Singapore) under the Competitive Research Programme (NRFCRP19-2017-02)."
    }, {
      "heading" : "Conflicts of interest",
      "text" : "There are no conflicts to declare."
    }, {
      "heading" : "Notes and references",
      "text" : "§ Live subject statement: The animal procedures were performed under the guidelines of the Agri-Food and Veterinary Authority (AVA) Rules and the National Advisory Committee for Laboratory Animal Research (NACLAR) of Singapore and approved by the Institutional Animal Care and Use Committee (IACUC, protocol number: 171289), BRC, A*STAR, Singapore.\n1 M. Benbow, Wound management. Evidence-based wound management, Whurr Publishers Ltd, London, 2005, pp. 19–31, 95–180. 2 M. C. Robson, Surg. Clin. North Am., 1997, 77, 637–650. 3 J. P. Heggers and M. C. Robson, Quantitative bacteriology: its role in\nthe Armamentarium of the surgeon, CRC Press, Boca Raton, FL, 1991. 4 T. Serena, M. C. Robson, D. M. Cooper and J. Ignatious, Wounds,\n2006, 18, 197–202. 5 A. Mikhaylova, B. Liesenfeld, D. Moore, W. Toreki, J. Vella, C. Batich\nand G. Schultz, Wounds, 2011, 23, 24–31. 6 International consensus, Appropriate use of silver dressings in\nwounds, Wounds International, London, 2012, available to download from www.woundsinternational.com. 7 L. W. Toy and L. Macera, J. Am. Acad. Nurse Pract., 2011, 23, 183–192. 8 C. Cochrane, M. Walker, P. Bowler, D. Parsons and D. Knottenbelt,\nWounds, 2006, 18, 29–34. 9 V. Poon and A. Burd, Burns, 2004, 30, 140–147.\n10 S.-B. Zou, W.-Y. Yoon, S.-K. Han, S.-H. Jeong, Z.-J. Cui and W.-K. Kim, Int. Wound J., 2013, 10, 306–312. 11 M. Innes, N. Umraw, J. Fish, M. Gomez and R. Cartotto, Burns, 2001, 6, 621–627. 12 A. Burd, Ch. H. Kwok, S. C. Hung, H. S. Chan, H. G. W. K. Lam and L. Huang, Wound Rep. Reg., 2007, 15, 94–104. 13 D. W. Brett, Ostomy/Wound Management, 2006, 52, 34–41. 14 W. Zhuang, D. Yuan, J.-R. Li, Z. Luo, H.-C. Zhou, S. Bashir and J. Liu,\nAdv. Healthcare Mater., 2012, 1, 225–238. 15 S. Aguado, J. Quirós, J. Canivet, D. Farrusseng, K. Boltes and\nR. Rosal, Chemosphere, 2014, 113, 188–192. 16 Y. Liu, X. Xu, Q. Xia, G. Yuan, Q. He and Y. Cui, Chem. Commun.,\n2010, 46, 2608–2610. 17 X. Lu, J. Ye, D. Zhang, R. Xie, R. F. Bogale, Y. Sun, L. Zhao, Q. Zhao\nand G. J. Ning, Inorg. Biochem., 2014, 138, 114–121. 18 C. Chiericatti, J. C. Basilico, M. L. Z. Basilico and J. M. Zamaro,\nMicroporous Mesoporous Mater., 2012, 162, 60–63. 19 A. R. Abbasi, K. Akhbari and A. Morsali, Ultrason. Sonochem., 2011,\n19, 846–852. 20 H. S. Rodriguez, J. P. Hinestroza, C. Ochoa-Puentes, C. A. Sierra and\nC. Y. Soto, J. Appl. Polym. Sci., 2014, 131, 40815. 21 C. Tamames-Tabar, E. Imbuluzqueta, N. Guillou, C. Serre, S. R. Miller,\nE. Elkaı̈m, P. Horcajada and M. J. Blanco-Prieto, CrystEngComm, 2015, 17, 456–462. 22 G. Wyszogrodzka, B. Marszałek, B. Gil and P. Dorożyński, Drug Discovery Today, 2016, 21, 1009–1018. 23 Y. Yuan and Y. Zhang, Nanomedicine, 2017, 13, 2199–2207. 24 JIS L 1902: 2002 (JAFET/JSA), Japanese Industrial Standard. 25 J. Hasan, R. J. Crawford and E. P. Ivanova, Trends Biotechnol., 2013,\n31, 295–304. 26 E. P. Ivanova, J. Hasan, H. K. Webb, G. Gervinskas, S. Juodkazis, V. K.\nTruong, A. H. F. Wu, R. N. Lamb, V. A. Baulin, G. S. Watson, J. A. Watson, D. E. Mainwaring and R. J. Crawford, Nat. Commun., 2013, 4, 2838–2841. 27 X. L. Li, Phys. Chem. Chem. Phys., 2016, 18, 1311–1316. 28 J. Hasan, H. K. Webb, V. K. Truong, S. Pogodin, V. A. Baulin,\nG. S. Watson, J. A. Watson, R. J. Crawford and E. P. Ivanova, Appl. Microbiol. Biotechnol., 2013, 97, 9257–9262. 29 K. Morimoto, T. Ozawa, K. Awazu, N. Ito, N. Honda, S. Matsumoto and D. Tsuruta, PLoS One, 2004, 9, e105173.\nFig. 8 ZIF-L coated gauze accelerates wound healing. Histological evaluation of infected wounds after 11 days of treatment with (a–d) the uncoated gauze, (e–g) the UrgoTuls Silver gauze and (h–j) the ZIF-L coated gauze. Arrows point to the edge of the wound (punched sites). Scale bar = 500 mm. A view of the complete section of the wound can be obtained by connecting a–d, e–g or h–j together (from left to right)."
    }, {
      "heading" : "Communication ChemComm",
      "text" : "Pu bl\nis he\nd on\n1 1\nD ec\nem be\nr 20\n18 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf N\new E\nng la\nnd o\nn 1/\n21 /2\n01 9\n2: 30\n:1 4\nA M\n. View Article Online"
    } ],
    "references" : [ {
      "title" : "IACUC, protocol number: 171289), BRC, A*STAR, Singapore",
      "author" : [ "M. Benbow" ],
      "venue" : "Whurr Publishers Ltd, London,",
      "citeRegEx" : "Benbow,? \\Q2005\\E",
      "shortCiteRegEx" : "Benbow",
      "year" : 2005
    } ],
    "referenceMentions" : [ ],
    "year" : 2019,
    "abstractText" : "Nano-dagger coated gauze was bactericidal against both Grampositive and Gram-negative bacteria, with log reduction 47 for Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus). Compared with the commercially available Ag gauze, the ZIF-L nano-dagger coated gauze was more biocompatible with a lower haemolytic activity, less cytotoxicity and improved wound healing performance. Animal studies showed that the ZIF-L coated gauze can effectively kill bacteria in a S. aureus wound infection model in mice. This novel nano-dagger coated gauze offers an effective and safe alternative for patients to protect against wound infections. This study demonstrates the first application of a MOF coating as an antibiotic-free wound dressing with potent antimicrobial activity and improved biocompatibility.",
    "creator" : null
  }
}